Advertisement Norgine licenses Moviprep to Nycomed - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Norgine licenses Moviprep to Nycomed

Norgine has given license to Nycomed to commercialize Moviprep in Tajikistan, Georgia, Russia, Azerbaijan, Armenia, Kazakhstan, Mongolia, Moldova, Kyrgyzstan, Uzbekistan and Ukraine.

Moviprep is a laxative solution that increases the amount of water in the intestinal tract to stimulate bowel movements.

This medication also contains potassium, sodium and other minerals to replace electrolytes that are passed from the body in the stool.

Financial terms of the agreement were not been disclosed.

Nycomed Russia-CIS president and Nycomed Group senior vice president Jostein Davidson said Moviprep has proven to be the preferred choice for bowel preparation in EU and Nycomed is proud to make this product a success in Russia/CIS improving quality of life of millions of patients.

Norgine CEO Peter Stein said they look forward to working with Nycomed to capitalize on their extensive sales and distribution network to help realize Moviprep’s potential in the CIS.